| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.04B | 44.62B | 43.55B | 37.77B | 34.54B | 33.56B |
| Gross Profit | 16.02B | 15.23B | 14.28B | 11.98B | 10.88B | 11.37B |
| EBITDA | 4.86B | 4.80B | 4.77B | 3.35B | 2.85B | 3.37B |
| Net Income | 2.71B | 2.65B | 2.77B | 1.63B | 1.24B | 1.62B |
Balance Sheet | ||||||
| Total Assets | 45.99B | 46.91B | 47.61B | 44.89B | 42.28B | 41.69B |
| Cash, Cash Equivalents and Short-Term Investments | 16.03B | 16.71B | 17.64B | 15.58B | 15.34B | 14.12B |
| Total Debt | 358.00M | 189.00M | 204.00M | 195.00M | 0.00 | 0.00 |
| Total Liabilities | 8.62B | 9.11B | 9.54B | 8.66B | 6.88B | 6.75B |
| Stockholders Equity | 37.37B | 37.79B | 38.07B | 36.23B | 35.40B | 34.94B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.00B | 3.36B | 1.09B | 2.02B | 2.30B |
| Operating Cash Flow | 0.00 | 3.33B | 4.27B | 1.68B | 2.87B | 3.26B |
| Investing Cash Flow | 0.00 | -469.00M | -1.17B | -636.00M | -1.53B | -697.00M |
| Financing Cash Flow | 0.00 | -2.73B | -1.06B | -810.00M | -805.00M | -804.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥46.91B | 14.35 | ― | 3.74% | 3.70% | 12.26% | |
66 Neutral | ¥104.70B | 13.03 | ― | 3.53% | -0.58% | -46.15% | |
66 Neutral | ¥126.22B | 10.42 | 12.89% | 3.40% | 2.98% | 41.11% | |
64 Neutral | ¥62.87B | 20.20 | ― | 1.49% | -8.92% | 1.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥5.96B | 4.98 | ― | 4.13% | 2.76% | -10.23% | |
50 Neutral | ¥468.86B | 16.11 | 1.44% | 4.80% | 0.68% | ― |